Skip to search formSkip to main contentSkip to account menu

tumor infiltrating lymphocyte therapy

Known as: TIL, therapy, tumor infiltrating lymphocyte 
A form of adoptive cell transfer in which lymphocytes are isolated from a patient's tumor, grown in vitro, and then infused into the patient in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Focal tumor cell PD-L1 expression adjacent to TIL can be used as a surrogate marker of an ongoing antitumor host response, which… 
Review
2014
Review
2014
Adoptive cell therapy for melanoma, particularly using TIL, consists of a complex and difficult set of procedures, although it… 
2014
2014
Reduced port surgery and single‐port surgery are currently in the spotlight as next‐generation, minimally invasive surgical… 
2007
2007
We previously demonstrated a dominant IgG response against XAGE-1b antigen in a lung cancer patient by serological analysis of… 
Highly Cited
1997
Highly Cited
1997
Despite increasing survival rates for patients with colorectal cancer, additional treatment options are required, including… 
1997
1997
Characterization of tumor-associated antigens (TAAs) recognized by CTLs makes the consideration of therapeutic strategies based… 
1994
1994
Cytotoxic T-lymphocytes (CTLs) can be isolated from human melanoma biopsies that specifically lyse autologous melanoma in vitro… 
1990
1990
TIL were cultured from human renal‐cell carcinoma (RCC) in 1,000 U/ml rIL2 and restimulated with autologous tumor in efforts to… 
1989
1989
It is thought that TIL can be activated in vitro by rIL‐2 and acquire specific anti‐tumor activity. In this study, we…